Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...
Discover how Pitavastatin, a cholesterol-lowering drug, shows promise as a treatment for triple-negative breast cancer.
Two related discoveries detailing nanocrystalline mineral formation and dynamics have broad implications for managing nuclear ...
Two related discoveries detailing nanocrystalline mineral formation and dynamics have broad implications for managing nuclear ...
Morning Overview on MSN
AlphaFold rewired science, and 5 years later it’s still evolving
AlphaFold arrived as a technical moonshot that suddenly made protein structures feel like software rather than secrets of ...
A study published Sunday by the journal Phytomedicine reports that the cannabis compound cannabidiol (CBD) demonstrated ...
Neuroscientists have been trying to understand how the brain processes visual information for over a century. The development of computational models inspired by the brain's layered organization, also ...
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...
News-Medical.Net on MSN
Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...
A Korea University research team has discovered that pitavastatin, a widely used lipid-lowering drug, can directly inhibit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback